CN117466958A - 假三糖氨基糖苷及其中间体的大规模制备 - Google Patents

假三糖氨基糖苷及其中间体的大规模制备 Download PDF

Info

Publication number
CN117466958A
CN117466958A CN202311295323.3A CN202311295323A CN117466958A CN 117466958 A CN117466958 A CN 117466958A CN 202311295323 A CN202311295323 A CN 202311295323A CN 117466958 A CN117466958 A CN 117466958A
Authority
CN
China
Prior art keywords
group
formula
protected
compound represented
acceptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311295323.3A
Other languages
English (en)
Chinese (zh)
Inventor
迈克尔·米吉瑞斯齐
马尼·布珊·科塔拉
拉文德尔·帕拉迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eloxx Pharmaceuticals Ltd
Original Assignee
Eloxx Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eloxx Pharmaceuticals Ltd filed Critical Eloxx Pharmaceuticals Ltd
Publication of CN117466958A publication Critical patent/CN117466958A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202311295323.3A 2017-03-15 2018-03-15 假三糖氨基糖苷及其中间体的大规模制备 Pending CN117466958A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201721008996 2017-03-15
IN201721008996 2017-03-15
CN201880032661.9A CN110637024B (zh) 2017-03-15 2018-03-15 假三糖氨基糖苷及其中间体的大规模制备
PCT/IL2018/050306 WO2018167794A1 (en) 2017-03-15 2018-03-15 Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201880032661.9A Division CN110637024B (zh) 2017-03-15 2018-03-15 假三糖氨基糖苷及其中间体的大规模制备

Publications (1)

Publication Number Publication Date
CN117466958A true CN117466958A (zh) 2024-01-30

Family

ID=63521924

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202311295323.3A Pending CN117466958A (zh) 2017-03-15 2018-03-15 假三糖氨基糖苷及其中间体的大规模制备
CN201880032661.9A Expired - Fee Related CN110637024B (zh) 2017-03-15 2018-03-15 假三糖氨基糖苷及其中间体的大规模制备

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201880032661.9A Expired - Fee Related CN110637024B (zh) 2017-03-15 2018-03-15 假三糖氨基糖苷及其中间体的大规模制备

Country Status (9)

Country Link
US (2) US11136345B2 (cg-RX-API-DMAC10.html)
EP (1) EP3609902A4 (cg-RX-API-DMAC10.html)
JP (1) JP7187471B2 (cg-RX-API-DMAC10.html)
CN (2) CN117466958A (cg-RX-API-DMAC10.html)
AU (2) AU2018235441C1 (cg-RX-API-DMAC10.html)
BR (1) BR112019018834A2 (cg-RX-API-DMAC10.html)
CA (1) CA3055883A1 (cg-RX-API-DMAC10.html)
IL (1) IL269364B (cg-RX-API-DMAC10.html)
WO (1) WO2018167794A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021061873A1 (en) * 2019-09-23 2021-04-01 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for treating polycystic kidney disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897412A (en) 1972-05-04 1975-07-29 Bristol Myers Co Paromomycin antibiotic derivatives
LU70223A1 (cg-RX-API-DMAC10.html) 1973-06-05 1976-04-13
US4029882A (en) 1974-03-19 1977-06-14 Schering Corporation Selective acylation of the C-1 amino group of aminoglycoside antibiotics
US3996205A (en) 1975-09-08 1976-12-07 The Upjohn Company Aminoglycoside antibiotics and intermediates
JPS543043A (en) 1977-06-10 1979-01-11 Meiji Seika Kaisha Ltd Amino-glycoside antibiotics; 1-n-(omega-aminoalkanesulfonyl)derivatives and their preparation
FR2427341A1 (fr) 1978-06-02 1979-12-28 Delalande Sa Nouveaux derives aminoglycosidiques hemisynthetiques, leur procede de preparation et leur application en therapeutique
JPH0446189A (ja) 1990-06-08 1992-02-17 Meiji Seika Kaisha Ltd 新規なリボスタマイシン誘導体
HUE031643T2 (en) 2006-04-03 2017-07-28 Technion Res & Dev Foundation New aminoglycosides and their applications in the treatment of genetic disorders
WO2011044538A1 (en) * 2009-10-09 2011-04-14 Achaogen, Inc. Antibacterial aminoglycoside analogs
RS56739B1 (sr) 2010-11-18 2018-03-30 Technion Res & Dev Foundation Aminoglikozidi i njihova upotreba u tretiranju genetskih poremećaja
EP3151840A1 (en) 2014-06-05 2017-04-12 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome
EP3344640A4 (en) * 2015-09-02 2019-05-01 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
US10786520B2 (en) * 2015-09-02 2020-09-29 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
CN114957357A (zh) 2015-09-02 2022-08-30 Eloxx制药有限公司 氨基糖苷衍生物及其在治疗遗传性病症中的应用

Also Published As

Publication number Publication date
EP3609902A4 (en) 2021-01-06
US20220033428A1 (en) 2022-02-03
CA3055883A1 (en) 2018-09-20
EP3609902A1 (en) 2020-02-19
US20200079809A1 (en) 2020-03-12
US11136345B2 (en) 2021-10-05
CN110637024B (zh) 2023-10-24
AU2022256098B2 (en) 2024-07-11
JP2020514373A (ja) 2020-05-21
BR112019018834A2 (pt) 2020-04-14
AU2022256098C1 (en) 2024-10-31
JP7187471B2 (ja) 2022-12-12
IL269364A (en) 2019-11-28
AU2018235441B2 (en) 2022-07-21
WO2018167794A1 (en) 2018-09-20
AU2018235441A2 (en) 2019-11-07
IL269364B (en) 2022-04-01
CN110637024A (zh) 2019-12-31
AU2022256098A1 (en) 2022-11-17
AU2018235441A1 (en) 2019-09-26
AU2018235441C1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
JP7335288B2 (ja) アミノグリコシド誘導体および遺伝性疾患の治療におけるその使用
US20230097398A1 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
CN102639531B (zh) 噻托溴铵的无水合物
US11786539B2 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
JP2018528211A5 (cg-RX-API-DMAC10.html)
JPH11514980A (ja) 官能的および空間的に多様な分子を製造するための分子骨格としての2−デオキシストレプタミンとその薬剤組成物
AU2022256098C1 (en) Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof
WO2017118968A1 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO1992019638A1 (en) 1-β-D-ARABINOFURANOSYL-(E)-5-(2-HALOGENOVINYL)-URACIL DERIVATIVE
JP5874871B1 (ja) C−4”位置換マクロライド化合物
KR101327797B1 (ko) 트리사이클로 화합물 당화 유도체
CN111087410A (zh) 一种阿莫西林杂质g的制备方法
JP2016199499A (ja) (2s)−2−メチルアミノ−n−ヒドロキシ−n’,2−ジメチルプロパンジアミドを有する化合物の結晶形及びそれらの製造方法
CN113105504A (zh) Remdesivir衍生物、其类似物及其制备方法与应用
WO2017142002A1 (ja) C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
JPS595191A (ja) セフチゾキシムのカルボキシメチルエステル及びその製造方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination